Brooks Automation develops products for the Semiconductor and Life Sciences industries.

In 2018, Brooks acquired gene synthesis company, GENEWIZ for $450 million. GENEWIZ synthesizes naturally occurring sequences, codon-optimized genes, gene libraries, complex sequences, large sequences. GENEWIZ first-quarter 2019 financials show that the company has generated $33 million in the quarter, with $16 million under Brooks ownership. While GENEWIZ is a global leader in the synthesizing genetic sequences, the space is becoming increasingly competitive with more companies developing faster synthesizing methods.